219
Views
0
CrossRef citations to date
0
Altmetric
Clinical features - Letter to the editor

Do you know about Kratom?

, &

References

  • Fluyau D, Revadigar N. Biochemical benefits, diagnosis, and clinical risks evaluation of Kratom. Front Psych. 2017;8:62. PMID: 28484399.
  • Cinosi E, Martinotti G, Corazza O. Following “The roots” of Kratom (Mitragyna speciosa): the evolution of an enhancer from a traditional use to increase work and productivity in Southeast Asia to a recreational psychoactive drug in Western Countries. Biomed Res Int. 2015;2015:968786. PMID: 26640804.
  • Veltri C, Grundmann O. Current perspectives on the impact of Kratom use. Subst Abuse Rehabil. 2019;10:23–31. PMID: 31308789.
  • Meireles V, Rosado T, Barroso M, et al. Mitragyna speciosa: clinical, toxicological aspects and analysis in biological and non-biological samples. Medicines (Basel). 2019 [Cited 2020 Apr 14];6(1):35. PMID: 30836609.
  • Olsen EO, O’Donnell J, Mattson CL, et al. Notes from the field: unintentional drug overdose deaths with Kratom detected — 27 States, July 2016–December 2017. MMWR Morb Mortal Wkly Rep. 2019 [cited 2020 Apr 14];68:326–327. Also - More deaths have been associated with kratom than previously known, Centers for Disease Control study finds https://www.cnn.com/2019/04/12/health/kratom-deaths-cdc-study/index.html Also accessed April 14, 2020.
  • Tayabali K, Bolzon C, Foster P, et al. Kratom: a dangerous player in the opioid crisis. J Comm Hosp Intern Med Perspect. 2018;8(3):107–110. PMID: 29915645.
  • What is kratom? National Institute of Drug Abuse. April 2019. cited 2020 Apr 14. Available at: https://www.drugabuse.gov/publications/drugfacts/kratom
  • The Kratom debate: helpful herb or dangerous drug? cited Apr 14, 2020. Available at: https://www.npr.org/sections/health-shots/2020/01/13/789145948/the-kratom-debate-helpful-herb-or-dangerous-drug

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.